These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 16177117

  • 1. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3',5'-cyclic monophosphate.
    von Bülow V, Rink L, Haase H.
    J Immunol; 2005 Oct 01; 175(7):4697-705. PubMed ID: 16177117
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM, Barnes PJ, Giembycz MA.
    Cell Biochem Biophys; 1998 Oct 01; 29(1-2):179-201. PubMed ID: 9631245
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A, Ono K, Sato Y, Shioi T, Nose Y, Sasayama S.
    J Mol Cell Cardiol; 1996 Dec 01; 28(12):2491-9. PubMed ID: 9004165
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of cyclic-3',5'-nucleotide phosphodiesterase abrogates the synergism of hypoxia with lipopolysaccharide in the induction of macrophage TNF-alpha production.
    Meng X, Ao L, Shames BD, Harken AH.
    J Surg Res; 2001 Dec 01; 101(2):210-5. PubMed ID: 11735278
    [Abstract] [Full Text] [Related]

  • 6. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
    Lugnier C, Schoeffter P, Le Bec A, Strouthou E, Stoclet JC.
    Biochem Pharmacol; 1986 May 15; 35(10):1743-51. PubMed ID: 2423089
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of a phosphodiesterase III in the lysis-sensitive target-induced elevation of cyclic AMP (cAMP) in human natural killer cells.
    Whalen MM, Crews JD.
    Biochem Pharmacol; 2000 Aug 15; 60(4):499-506. PubMed ID: 10874124
    [Abstract] [Full Text] [Related]

  • 8. Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases.
    Guo L, Luo L, Ju R, Chen C, Zhu L, Li J, Yu X, Ye C, Zhang D.
    Eur J Pharmacol; 2015 Jan 05; 746():14-21. PubMed ID: 25446933
    [Abstract] [Full Text] [Related]

  • 9. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M, Pekkinen M, Huttunen M, Lamberg-Allardt C.
    Cell Mol Biol Lett; 2005 Jan 05; 10(2):305-19. PubMed ID: 16010295
    [Abstract] [Full Text] [Related]

  • 10. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM, Barnes PJ, Meja K, Giembycz MA.
    Mol Pharmacol; 1995 Oct 05; 48(4):747-57. PubMed ID: 7476903
    [Abstract] [Full Text] [Related]

  • 11. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
    Verghese MW, McConnell RT, Strickland AB, Gooding RC, Stimpson SA, Yarnall DP, Taylor JD, Furdon PJ.
    J Pharmacol Exp Ther; 1995 Mar 05; 272(3):1313-20. PubMed ID: 7891349
    [Abstract] [Full Text] [Related]

  • 12. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages.
    Kambayashi T, Jacob CO, Zhou D, Mazurek N, Fong M, Strassmann G.
    J Immunol; 1995 Nov 15; 155(10):4909-16. PubMed ID: 7594495
    [Abstract] [Full Text] [Related]

  • 13. Zinc-dependent suppression of TNF-alpha production is mediated by protein kinase A-induced inhibition of Raf-1, I kappa B kinase beta, and NF-kappa B.
    von Bülow V, Dubben S, Engelhardt G, Hebel S, Plümäkers B, Heine H, Rink L, Haase H.
    J Immunol; 2007 Sep 15; 179(6):4180-6. PubMed ID: 17785857
    [Abstract] [Full Text] [Related]

  • 14. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells.
    Endres S, Fülle HJ, Sinha B, Stoll D, Dinarello CA, Gerzer R, Weber PC.
    Immunology; 1991 Jan 15; 72(1):56-60. PubMed ID: 1847694
    [Abstract] [Full Text] [Related]

  • 15. Interaction of cyclic GMP and cyclic AMP during neutrophil migration: involvement of phosphodiesterase type III.
    VanUffelen BE, de Koster BM, Elferink JG.
    Biochem Pharmacol; 1998 Oct 15; 56(8):1061-3. PubMed ID: 9776319
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE, Lugnier C.
    Br J Pharmacol; 1994 Oct 15; 113(2):445-50. PubMed ID: 7834194
    [Abstract] [Full Text] [Related]

  • 18. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
    Foey AD, Field S, Ahmed S, Jain A, Feldmann M, Brennan FM, Williams R.
    Arthritis Res Ther; 2003 Oct 15; 5(6):R317-28. PubMed ID: 14680506
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.